Allergy Screen
Transthyretin (TTR) Gene Mutation Analysis
Interleukin 6 (IL-6), Serum
Prosigna Breast Cancer Prognostic Gene Signature
Hepatitis D Virus (HDV) Antigen
Toxoplasma Gondii IgG and IgM, CSF
Culture, Bronchoalveolar Lavage
Acetoacetate (Ketones), Serum
Lithium, Serum
Bruton Tyrosine Kinase (BTK) Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
CPT
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now